FREE Shippingto US, AU, UK and EU on all orders over $149

Description

The instruction for medical use
of medicine

of Ellick

the Trade name
of Ellick

the International unlicensed

name Mometazon Lekarstvennaya a form
Ointment of 0.1%

Structure
of 1 g of ointment contains
active agent – a mometazon furoate of 1 mg,
excipients: white vaseline.

The description
of White or almost white color the ointment, uniform, without foreign inclusions.

Pharmacotherapeutic group
Glucocorticoids for topical treatment of diseases of skin. Glucocorticoids active (group III)
the Code of automatic telephone exchange D07AC13

the Pharmacological

Pharmacokinetics Biological Availability properties of a mometazon of furoate when drawing on skin is very low (0.7%). Use of hermetic bandages or drawing on the inflamed skin leads to increase in extent of absorption of a mometazon. Extent of penetration of corticosteroids of topical administration through skin depends on many factors, including composition of drug and integrity of an epidermal barrier and varies substantially at different individuals and in different anatomic sites of skin: a forearm – 1%, the head – 4%, a forehead – 7%, a scrotum – 36%. The greatest extent of absorption of a mometazon is noted when putting ointment on skin inguinal, an underarm, face skin.
After topical administration of a mometazon, furoate is exposed to extensive metabolism in a liver.
Are removed generally through kidneys, and in a small amount – with bile. Elimination half-life of drug makes 5.8 hours.

Mometazon’s pharmacodynamics furoate, active agent of ointment of Ellick, is a synthetic galogensoderzhashchy corticosteroid and possesses anti-inflammatory, antipruritic, vasoconstrictive action.

Indications
– the inflammatory phenomena and an itching at a dermatosis
– psoriasis, atopic dermatitis
– seborrheal dermatitis

the Route of administration and
Ellick’s doses apply ointment a thin layer on an affected area once a day.
Duration of a course of topical treatment of dermatitis – from 3 days to 3 weeks.
Topical treatment of psoriasis – 3 days.
Duration of a course of treatment is defined by its efficiency and also shipping of patients, existence and severity of side effects.

Side effects
– parasthesias, pruritus, a burn, a folliculitis, a skin atrophy
– inflammation of integuments, gipertrikhozis, hypopigmentation
– oral dermatitis, allergic contact dermatitis, maceration
of skin, consecutive infection
Very seldom
– papulation
– adrenal insufficiency and Cushing’s syndrome (at
ointment use for a long time and/or for treatment of big sites
of skin, or with use of occlusive bandages, especially at children and
teenagers)

Contraindications
– hypersensitivity to a mometazon to furoate and to other components
of drug, or to corticosteroids.
– pink eels, perioral dermatitis
– bacterial, virus (Herpes simplex, chicken pox, Herpes zoster) or
a fungal infection of skin
– tuberculosis, syphilis
– vaccine-challenged reactions
– children’s age up to 2 years
– pregnancy and the period of a lactation

Medicinal interaction
Medicinal interactions are not described.

Special instructions
It is necessary to avoid hit of ointment of Ellick in eyes.
When drawing on big sites of skin for a long time, especially at use of occlusive bandages, development of systemic action of a mometazon is possible. Considering it, patients have to be observed concerning signs of suppression of function gipotalamo – the hypophysial and adrenal system and development of a syndrome of Cushing.
It is necessary to consider that GKS-soderzhashchiye ointments are capable to change manifestations of some diseases of skin that can complicate diagnosis and besides, be the cause of a delay of healing of wounds.
At long therapy of GKS the sudden termination of therapy can lead ment of a syndrome of the ricochet which is shown in the form of dermatitis with intensive erubescence and burning sensation. Therefore after a long course of treatment the drug withdrawal should be made gradually, for example, passing to the intermittent scheme of treatment before completely to stop it.
Use in pediatrics
Because children have a size of a ratio of surface area and body weight is more, than at adults, children are subject to bigger risk of suppression of function gipotalamo – the hypophysial and adrenal system and development of a syndrome of Cushing at use of any GKS of local action.
Long GKS-treatment of children can lead to disturbances of their growth and development.
Children have to receive the minimum dose of drug sufficient for achievement of effect.
Features of influence of medicine on ability to run motor transport or other potentially dangerous mechanisms
are not revealed.

Overdose
Symptoms: excessive or prolonged use of local glucocorticosteroids can cause oppression of function of a hypophysial and adrenal system that can become the reason of development of secondary insufficiency of bark of adrenal glands.
Treatment: symptomatic. Acute symptoms of a hypercorticoidism are usually reversible. If necessary correction of an electrolytic imbalance is shown. In case of chronic toxic action the gradual cancellation of glucocorticosteroids is recommended.

A form of release and packing
On 30 g in an aluminum tuba. On 1 tuba together with the instruction for use in the state and Russian languages put in a pack from cardboard.

Storage conditions
In the place protected from light, at a temperature from 150 With to 250 C
to Store out of children’s reach!

2 years
not to apply a period of storage after an expiration date.

Prescription status
According to the prescription

the Producer
Jamjoom Pharmaceutical Co. Ltd, Jeddah, Saudi Arabia
Saudi Arabia, Mr. Zhedakh, Industrialnaya Square phase 5,
ph./fax +966 2 6081111 / +966 2 6081222
e-mail: www.jamjoompharma.com, salmanhussain@jamjoompharma.co

the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods)
Republic of Kazakhstan, city of Almaty, Al-Farabi Avenue, 15 of the Centre Party of Finland of ‘Nurla Tau’, block 4’B’, office No. 18. Phone number: 251 98 22, 8702 198 65 74, E-mail address: pharmacovigilance@jamjoompharma.com

Additional information

Ingredient

Reviews

There are no reviews yet.

Be the first to review “Elika 30g Ointment”

Your email address will not be published.